Search Results - "Charreau, E H"

Correction: Targeting ErbB-2 nuclear localization and function inhibits breast cancer growth and overcomes trastuzumab resistance by Russo, R. I. Cordo, Béguelin, W., Flaqué, M. C. Díaz, Proietti, C. J., Venturutti, L., Galigniana, N., Tkach, M., Guzmán, P., Roa, J. C., O’Brien, N. A., Charreau, E. H., Schillaci, R., Elizalde, P. V.

Get full text

Correction: Stat3 regulates ErbB-2 expression and co-opts ErbB-2 nuclear function to induce miR-21 expression, PDCD4 downregulation and breast cancer metastasis by Venturutti, L., Romero, L. V., Urtreger, A. J., Chervo, M. F., Russo, R. I. Cordo, Mercogliano, M. F., Inurrigarro, G., Pereyra, M. G., Proietti, C. J., Izzo, F., Díaz Flaqué, M. C., Sundblad, V., Roa, J. C., Guzmán, P., de Kier Joffé, E. D. Bal, Charreau, E. H., Schillaci, R., Elizalde, P. V.

Get full text

Correction: MiR-16 mediates trastuzumab and lapatinib response in ErbB-2-positive breast and gastric cancer via its novel targets CCNJ and FUBP1 by Venturutti, L., Russo, R. I. Cordo, Rivas, M. A., Mercogliano, M. F., Izzo, F., Oakley, R. H., Pereyra, M. G., De Martino, M., Proietti, C. J., Yankilevich, P., Roa, J. C., Guzmán, P., Cortese, E., Allemand, D. H., Huang, T. H., Charreau, E. H., Cidlowski, J. A., Schillaci, R., Elizalde, P. V.

Get full text

MiR-16 mediates trastuzumab and lapatinib response in ErbB-2-positive breast and gastric cancer via its novel targets CCNJ and FUBP1 by Venturutti, L, Cordo Russo, R I, Rivas, M A, Mercogliano, M F, Izzo, F, Oakley, R H, Pereyra, M G, De Martino, M, Proietti, C J, Yankilevich, P, Roa, J C, Guzmán, P, Cortese, E, Allemand, D H, Huang, T H, Charreau, E H, Cidlowski, J A, Schillaci, R, Elizalde, P V

“…ErbB-2 amplification/overexpression accounts for an aggressive breast cancer (BC) subtype (ErbB-2-positive). Enhanced ErbB-2 expression was also found in…”
Get full text

Progestin-induced caveolin-1 expression mediates breast cancer cell proliferation by SALATINO, M, BEGUELIN, W, ELIZALDE, P. V, PETERS, M. G, CARNEVALE, R, PROIETTI, C. J, GALIGNIANA, M. D, VEDOY, C. G, SCHILLACI, R, CHARREAU, E. H, SOGAYAR, M. C

“…Progestin regulation of gene expression was assessed in the progestin-dependent murine tumor line C4HD which requires MPA, a synthetic progestin, for in vivo…”
Get full text

Stat3 regulates ErbB-2 expression and co-opts ErbB-2 nuclear function to induce miR-21 expression, PDCD4 downregulation and breast cancer metastasis by Venturutti, L, Romero, L V, Urtreger, A J, Chervo, M F, Cordo Russo, R I, Mercogliano, M F, Inurrigarro, G, Pereyra, M G, Proietti, C J, Izzo, F, Díaz Flaqué, M C, Sundblad, V, Roa, J C, Guzmán, P, Bal de Kier Joffé, E D, Charreau, E H, Schillaci, R, Elizalde, P V

“…Membrane overexpression of the receptor tyrosine kinase ErbB-2 (MErbB-2) accounts for a clinically aggressive breast cancer (BC) subtype (ErbB-2-positive) with…”
Get full text

Targeting ErbB-2 nuclear localization and function inhibits breast cancer growth and overcomes trastuzumab resistance by Cordo Russo, R I, Béguelin, W, Díaz Flaqué, M C, Proietti, C J, Venturutti, L, Galigniana, N, Tkach, M, Guzmán, P, Roa, J C, O'Brien, N A, Charreau, E H, Schillaci, R, Elizalde, P V

“…Membrane overexpression of ErbB-2/HER2 receptor tyrosine kinase (membrane ErbB-2 (MErbB-2)) has a critical role in breast cancer (BC). We and others have also…”
Get full text

Interactions between progestins and heregulin (HRG) signaling pathways : HRG acts as mediator of progestins proliferative effects in mouse mammary adenocarcinomas by BALANA, M. E, LUPU, R, LABRIOLA, L, CHARREAU, E. H, ELIZALDE, P. V

“…The present study addressed links between progestin and heregulin (HRG) signaling pathways in mammary tumors. An experimental model of hormonal carcinogenesis,…”
Get full text

Nitric oxide inhibits Leydig cell steroidogenesis by Del Punta, K, Charreau, E H, Pignataro, O P

“…Testicular macrophages as well as endothelial cells, which are intimately associated with Leydig cells, constitute a potential source of paracrine nitric oxide…”
Get full text

Role of receptors for epidermal growth factor and insulin-like growth factors I and II in the differentiation of rat mammary glands from lactogenesis I to lactogenesis II by Bussmann, L E, Bussmann, I M, Charreau, E H

“…In addition to ovarian steroids and lactogenic hormones from the placenta and pituitary, growth factors control the growth and differentiation of mammary…”
Get full text

Promoter effect of medroxyprogesterone acetate (MPA) in N-methyl-N-nitrosourea (MNU) induced mammary tumors in BALB/c mice by PAZOS, P, LANARI, C, ELIZALDE, P, MONTECCHIA, F, CHARREAU, E. H, MOLINOLO, A. A

“…The promoter effect of medroxyprogesterone acetate (MPA) on mammary carcinogenesis in female BALB/c mice was investigated using methylnitrosourea (MNU) as…”
Get full text

Mouse mammary tumors induced by medroxyprogesterone acetate: immunohistochemistry and hormonal receptors by Molinolo, A A, Lanari, C, Charreau, E H, Sanjuan, N, Pasqualini, C D

“…Mammary adenocarcinomas induced by medroxyprogesterone acetate (MPA) in female BALB/c mice were investigated as to their morphology and immunohistochemistry…”
Get more information

Nitric oxide inhibits Leydig cell steroidogenesis by Del Punta, K, Charreau, E H, Pignataro, O P

“…Testicular macrophages as well as endothelial cells, which are intimately associated with Leydig cells, constitute a potential source of paracrine nitric oxide…”
Get full text

Effect of medroxyprogesterone acetate (MPA) and serum factors on cell proliferation in primary cultures on an MPA-induced mammary adenocarcinoma by DRAN, G, LUTHY, I. A, MOLINOLO, A, MONTECCHIA, F, CHARREAU, E. H, PASQUALINI, C. D, LANARI, C

“…The effect of progesterone (Pg), medroxyprogesterone acetate (MPA), estradiol (E2), dihydrotestosterone (DHT) and dexamethasone (DEXA) was studied on the in…”
Get full text

Seasonal variations in testicular LH, FSH, and PRL receptors; in vitro testosterone production; and serum testosterone concentration in adult male vizcacha (Lagostomus maximus maximus) by Fuentes, L B, Calvo, J C, Charreau, E H, Guzmán, J A

“…Seasonal changes in the reproductive activity of the adult male vizcacha (Lagostomus maximus maximus), a South American rodent, were investigated. Monthly, for…”
Get more information

Measurement of specific radioactivities in labelled hormones by self-displacement analysis by Calvo, J C, Radicella, J P, Charreau, E H

“…A graphical method is described that allows the determination of specific radioactivities of radioactively labelled hormones. This method combines the…”
Get full text

Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleotides to type I insulin-like growth factor receptor mRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signaling pathways but not modulation of progesterone receptor activity by SALATINO, Mariana, SCHILLACI, Roxana, PROIETTI, Cecilia J, CARNEVALE, Romina, FRAHM, Isabel, MOLINOLO, Alfredo A, IRIBARREN, Adolfo, CHARREAU, Eduardo H, ELIZALDE, Patricia V

“…The present study addresses the effect of targeting type I insulin-like growth factor receptor (IGF-IR) with antisense strategies in in vivo growth of breast…”
Get full text

Involvement of insulin-like growth factors-I and -II and their receptors in medroxyprogesterone acetate-induced growth of mouse mammary adenocarcinomas by Elizalde, Patricia V., Lanari, Claudia, Molinolo, Alfredo A., Guerra, Fabiana K., Balañá, Maria E., Simian, Marina, Iribarren, Adolfo M., Charreau, Eduardo H.

“…The role of the insulin-like growth factors (IGFs) system was investigated in hormone-dependent (HD) and -independent (HI) in vivo lines of the…”
Get full text

Activation of ErbB-2 via a hierarchical interaction between ErbB-2 and type I insulin-like growth factor receptor in mammary tumor cells by BALANA, Maria Eugenia, LABRIOLA, Leticia, SALATINO, Mariana, MOVSICHOFF, Federico, PETERS, Giselle, CHARREAU, Eduardo H, ELIZALDE, Patricia V

“…The present study focused on interactions between signaling pathways activated by progestins and by type I and II receptor tyrosine kinases (RTKs) in mammary…”
Get full text

Heregulin Induces Transcriptional Activation of the Progesterone Receptor by a Mechanism That Requires Functional ErbB-2 and Mitogen-Activated Protein Kinase Activation in Breast Cancer Cells by Labriola, Leticia, Salatino, Mariana, Proietti, Cecilia J., Pecci, Adalí, Coso, Omar A., Kornblihtt, Alberto R., Charreau, Eduardo H., Elizalde, Patricia V.

“…Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text